These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5877110)

  • 1. [Inhibition of venoconstriction induced by 5-hydroxytryptamine in man by methysergide (UMI-491) and other serotonin antagonists].
    Sicuteri F; Fanciullacci M; Del Bianco PL; Franchi G
    Boll Soc Ital Biol Sper; 1964 Oct; 40(19):1151-2. PubMed ID: 5877110
    [No Abstract]   [Full Text] [Related]  

  • 2. [The test of venoconstriction for the measurement of sensitivity to 5-hydroxytryptamine and catecholamines in man].
    Sicuteri F; Del Bianco PL; Fanciullacci M; Franchi G
    Boll Soc Ital Biol Sper; 1964 Oct; 40(19):1148-50. PubMed ID: 5877109
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of hypoglycemia-induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide.
    Bivens CH; Lebovitz HE; Feldman JM
    N Engl J Med; 1973 Aug; 289(5):236-9. PubMed ID: 4713762
    [No Abstract]   [Full Text] [Related]  

  • 4. [Altered reactivity to 5-hydroxytryptamine and noradrenaline caused by monamine oxidase inhibitors in man].
    Sicuteri F; Fanciullacci M; Del Bianco PL
    Boll Soc Ital Biol Sper; 1965 May; 41(9):467-71. PubMed ID: 5876768
    [No Abstract]   [Full Text] [Related]  

  • 5. [Facilitation of the venoconstrictor action of 5-hydroxytryptamine by ergotamine, methysergide and LSD-25 in humans].
    Fanciullacci M; Franchi G; Sicuteri F
    Boll Soc Ital Biol Sper; 1975 Apr; 51(8):517-22. PubMed ID: 1212344
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
    Hardebo JE; Edvinsson L; Owman C; Svendgaard NA
    Neurology; 1978 Jan; 28(1):64-70. PubMed ID: 563539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of serotonin-induced blood cell aggregation in the dog.
    Pitzele S; Sze S; Dobell AR
    Surgery; 1973 Mar; 73(3):416-22. PubMed ID: 4687799
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of vasoactive agents and micro-emboli on the pulmonary circulation.
    Hageman WE; Wentling DG; Pruss TP
    Eur J Pharmacol; 1973 Jun; 22(3):295-303. PubMed ID: 4354578
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of effect of antagonists on serotonin-induced inhibition in rat hippocampus.
    Penington NJ; Reiffenstein RJ
    Can J Physiol Pharmacol; 1986 Nov; 64(11):1413-8. PubMed ID: 3791042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroidogenesis by isolated human adrenal cells: effect of serotonin and serotonin antagonists.
    Rácz K; Wolf I; Kiss R; Lada G; Vida S; Gláz E
    Experientia; 1979 Nov; 35(11):1532-4. PubMed ID: 228968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serotonin and antiserotonergic agents].
    Bourin M
    Rev Prat; 1990 Jun; 40(18):1711-3. PubMed ID: 2371526
    [No Abstract]   [Full Text] [Related]  

  • 12. Blocking effects of cyproheptadine and methysergide upon two different cardiovascular responses to serotonin.
    Hageman GR; James TN; Urthaler F
    Proc Soc Exp Biol Med; 1980 Dec; 165(3):420-3. PubMed ID: 7465555
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of 5-HT and its antagonists on contraction of the anterior tibial muscle in the rat].
    Mitolo-Chieppa D
    Boll Soc Ital Biol Sper; 1968 Jan; 44(2):96-9. PubMed ID: 5651989
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative effects of noradrenaline and serotonin in a central and a peripheral artery in vitro.
    Tayo FM
    Afr J Med Med Sci; 1983; 12(3-4):139-43. PubMed ID: 6326547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of cyproheptadine, methysergide, BC 105 and reserpine on brain 5-hydroxytryptamine and brain growth.
    Hole K
    Eur J Pharmacol; 1972 Aug; 19(2):156-9. PubMed ID: 5071787
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of 5-hydroxytryptamine antagonists on spinal neuronal activity.
    Banna NR; Anderson EG
    J Pharmacol Exp Ther; 1968 Aug; 162(2):319-25. PubMed ID: 5302116
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of antimigraine drugs on the vascular responses by-5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action.
    Saxena PR
    Headache; 1972 Jul; 12(2):44-54. PubMed ID: 5056178
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadine.
    Plonk JW; Bivens CH; Feldman JM
    J Clin Endocrinol Metab; 1974 May; 38(5):836-40. PubMed ID: 4823925
    [No Abstract]   [Full Text] [Related]  

  • 19. Collaboration of serotonin and melatonin in the control of thyroid function.
    Csaba G; Richter T
    Acta Biol Med Ger; 1975; 34(6):1097-100. PubMed ID: 1199627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism by methysergide of vascular effects of 5-hydroxytryptamine in man.
    Walsh JA
    Br J Pharmacol Chemother; 1967 Aug; 30(3):518-30. PubMed ID: 6050497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.